Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Digoxin as Adjuvant for D&E at 20-24 Weeks
NCT03136068Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Feb 2017
- Primary completion
- May 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in abortion comparing Digoxin Arm with Placebo Arm (2 arms). Primary endpoint: Procedure Duration at Day 2. Started Feb 2017; status: completed.
02
Drugs
digoxin
03
Conditions
abortion
Beyond the preview
Go deeper on NCT03136068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03136068.